Women and HIV in British Columbia

Women make up approximately 18% of the population living with HIV in British Columbia. Women living with HIV can face unique barriers to care and challenges adhering to antiretroviral therapy (ART), compared with men. As a result, women often are not fully benefitting from the life-saving treatment available to them. In this issue of the HIV Pulse, we report on women living with HIV in British Columbia, using data from recent BC-CfE publications, the Provincial Quarterly Monitoring Reports and the BCCDC 2014 HIV Annual Report.

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below